Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |